InMed Pharmaceuticals (INM) EBT Growth (1y) (2022 - 2026)
InMed Pharmaceuticals (INM) EBT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 48.64% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -393.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -24.84% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 92.01% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,578.91% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 45.00% |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - | -35.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.06% |
| Dec 31, 2025 | 21.23% |
| Sep 30, 2025 | -2.92% |
| Jun 30, 2025 | 32.33% |
| Mar 31, 2025 | -19.98% |
| Dec 31, 2024 | -74.20% |
| Sep 30, 2024 | 33.86% |
| Jun 30, 2024 | -473.57% |
| Mar 31, 2024 | 13.70% |
| Dec 31, 2023 | 29.55% |
| Sep 30, 2023 | 27.59% |
| Jun 30, 2023 | 95.72% |
| Mar 31, 2023 | 42.56% |
| Dec 31, 2022 | 51.01% |
| Sep 30, 2022 | -17.90% |